Evidence map›Paper›PMID 33760876›Full record

ArticlePloS one2021

A faster and less costly alternative for RNA extraction of SARS-CoV-2 using proteinase k treatment followed by thermal shock.

Adolfo Marcelo Ñique, Fiorella Coronado-Marquina, Jairo Andrés Mendez Rico, María Paquita García Mendoza, Nancy Rojas-Serrano, Paulo Vitor Marques Simas, Cesar Cabezas Sanchez, Jan Felix Drexler

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Dry Swab-Based Nucleic Acid Extraction vs. Spin Column-Based Nucleic Acid Extraction for COVID-19 RT-PCR Testing: A Comparative Study.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. SwabExpress: An end-to-end protocol for extraction-free COVID-19 testing.bioRxiv : the preprint server for biology · 2021
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adolfo Marcelo ÑiqueNational Institute of Health-INS (Instituto Nacional de Salud-INS), Lima, Peru.
Fiorella Coronado-MarquinaNational Institute of Health-INS (Instituto Nacional de Salud-INS), Lima, Peru.
Jairo Andrés Mendez RicoPan American Health Organization-PAHO, Washington, DC, United States of America.
María Paquita García MendozaNational Institute of Health-INS (Instituto Nacional de Salud-INS), Lima, Peru.
Nancy Rojas-SerranoNational Institute of Health-INS (Instituto Nacional de Salud-INS), Lima, Peru.
Paulo Vitor Marques SimasNational Institute of Health-INS (Instituto Nacional de Salud-INS), Lima, Peru.ORCID 0000-0003-2241-6915
Cesar Cabezas SanchezNational Institute of Health-INS (Instituto Nacional de Salud-INS), Lima, Peru.
Jan Felix DrexlerCharité-Universitätsmedizin Berlin, Berlin, Germany.

Funding

World Health Organization 001
6 · The paper itself

Abstract

One of the biggest challenges during the pandemic has been obtaining and maintaining critical material to conduct the increasing demand for molecular tests. Sometimes, the lack of suppliers and the global shortage of these reagents, a consequence of the high demand, make it difficult to detect and diagnose patients with suspected SARS-CoV-2 infection, negatively impacting the control of virus spread. Many alternatives have enabled the continuous processing of samples and have presented a decrease in time and cost. These measures thus allow broad testing of the population and should be ideal for controlling the disease. In this sense, we compared the SARS-CoV-2 molecular detection effectiveness by Real time RT-PCR using two different protocols for RNA extraction. The experiments were conducted in the National Institute of Health (INS) from Peru. We compared Ct values average (experimental triplicate) results from two different targets, a viral and internal control. All samples were extracted in parallel using a commercial kit and our alternative protocol-samples submitted to proteinase K treatment (3 μg/μL, 56°C for 10 minutes) followed by thermal shock (98°C for 5 minutes followed by 4°C for 2 minutes); the agreement between results was 100% in the samples tested. In addition, we compared the COVID-19 positivity between six epidemiological weeks: the initial two in that the Real time RT-PCR reactions were conducted using RNA extracted by commercial kit, followed by two other using RNA obtained by our kit-free method, and the last two using kit once again; they did not differ significantly. We concluded that our in-house method is an easy, fast, and cost-effective alternative method for extracting RNA and conducing molecular diagnosis of COVID-19.

Indexed as

Clinical Laboratory TechniquesCOVID-19COVID-19 TestingDiagnostic Tests, RoutineEndopeptidase KHumansPandemicsPeruReal-Time Polymerase Chain ReactionRNARNA, ViralSARS-CoV-2Endopeptidase KRNARNA, Viral

Identifiers

PMID33760876
PMCPMC7990203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.